SinghH, RupalA, Al OmariO, et al.Trends in pulmonary tuberculosis mortality between 1985 and 2018: An observational analysis. BMC Pulm Med, 2023; 23(1):1–12; doi: 10.1186/s12890-023-02458-9
2.
DhivyaLS, SarveshS. Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: A molecular modelling analysis and in-vitro evidence. J Biomol Struct Dyn, 2023; 41(12):5399–5417; doi: 10.1080/07391102.2022.2086922
3.
RamachandranA, GadgilC. A Physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites. CPT Pharmacometrics Syst Pharmacol, 2023; 12(9):1274–1284; doi: 10.1002/psp4.13008
4.
BaykanAH, SayinerHS, AydinE, et al.Extrapulmonary tuberculosıs: An old but resurgent problem. Insights Imaging, 2022; 13(1):1–21; doi: 10.1186/s13244-022-01172-0
